Canaccord Genuity Maintains Buy on Hims & Hers Health, Raises Price Target to $38
Canaccord Genuity Maintains Buy on Hims & Hers Health, Raises Price Target to $38
Canaccord Genuity維持對Hims & Hers Health的買入評級，將價格目標上調至38美元
Canaccord Genuity analyst Maria Ripps maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises the price target from $28 to $38.
Canaccord Genuity分析師Maria Ripps維持Hims & hers Health（紐交所:HIMS）的買入評級，並將目標價格從28美元上調至38美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間